BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ashley J, Sood MM. Novel oral anticoagulants in chronic kidney disease: ready for prime time? Curr Opin Nephrol Hypertens 2018;27:201-8. [PMID: 29570468 DOI: 10.1097/MNH.0000000000000410] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Khan Y, Zaidi SO, Razak BS, Zaki M, Malik BH. Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients. Cureus 2020;12:e7007. [PMID: 32206471 DOI: 10.7759/cureus.7007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Jang SM, Bahjri K, Tran H. Safety and Efficacy of Direct Oral Anticoagulants for Atrial Fibrillation in Patients with Renal Impairment. Pharmacy (Basel) 2020;8:E30. [PMID: 32143504 DOI: 10.3390/pharmacy8010030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]